International Biotechnology (IBT) Competitors

International Biotechnology (LON:IBT) and ICG Enterprise Trust (LON:ICGT) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

Does the media prefer IBT or ICGT?

In the previous week, ICG Enterprise Trust had 1 more articles in the media than International Biotechnology. MarketBeat recorded 2 mentions for ICG Enterprise Trust and 1 mentions for International Biotechnology. ICG Enterprise Trust's average media sentiment score of 1.84 beat International Biotechnology's score of 1.05 indicating that ICG Enterprise Trust is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
International Biotechnology	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICG Enterprise Trust	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Is IBT or ICGT a better dividend stock?

International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 4.3%. ICG Enterprise Trust pays an annual dividend of GBX 34 per share and has a dividend yield of 2.4%. International Biotechnology pays out 27.7% of its earnings in the form of a dividend. ICG Enterprise Trust pays out 67.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. International Biotechnology is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has preferable earnings & valuation, IBT or ICGT?

International Biotechnology has higher earnings, but lower revenue than ICG Enterprise Trust. International Biotechnology is trading at a lower price-to-earnings ratio than ICG Enterprise Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Biotechnology	£41.82M	5.79	£37.91M	£104.80	6.43
ICG Enterprise Trust	£55.63M	16.50	£32.56M	£50.08	28.35

Do institutionals and insiders have more ownership in IBT or ICGT?

45.2% of International Biotechnology shares are owned by institutional investors. Comparatively, 65.6% of ICG Enterprise Trust shares are owned by institutional investors. 4.2% of International Biotechnology shares are owned by company insiders. Comparatively, 12.3% of ICG Enterprise Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is IBT or ICGT more profitable?

International Biotechnology has a net margin of 90.66% compared to ICG Enterprise Trust's net margin of 58.54%. International Biotechnology's return on equity of 13.67% beat ICG Enterprise Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Biotechnology	90.66%	13.67%	3.57%
ICG Enterprise Trust	58.54%	2.61%	0.78%

Which has more risk & volatility, IBT or ICGT?

International Biotechnology has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Comparatively, ICG Enterprise Trust has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

Summary

ICG Enterprise Trust beats International Biotechnology on 8 of the 15 factors compared between the two stocks.